AF
ABBV icon

Aldebaran Financial’s AbbVie ABBV Stock Holding History

Aldebaran Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$994K Buy
4,570
+295
+7% +$65.4K 0.94% 25
2025
Q4 		$982K Buy
4,275
+455
+12% +$104K 0.91% 26
2025
Q3 		$884K Buy
3,820
+765
+25% +$156K 0.88% 27
2025
Q2 		$567K Buy
3,055
+10
+0.3% +$1.86K 0.63% 41
2025
Q1 		$638K Buy
3,045
+381
+14% +$74.1K 0.78% 35
2024
Q4 		$469K Buy
2,664
+304
+13% +$55.9K 0.55% 48
2024
Q3 		$466K Buy
+2,360
New +$440K 0.55% 44
2024
Q2 		– Sell
-1,100
Closed -$200K – 65
2024
Q1 		$200K Buy
+1,100
New +$190K 0.28% 62
2023
Q1 		– Sell
-2,950
Closed -$477K – 73
2022
Q4 		$477K Hold
2,950
– – 0.51% 51
2022
Q3 		$401K Hold
2,950
– – 0.44% 56
2022
Q2 		$450K Sell
2,950
-6,925
-70% -$1.06M 0.48% 52
2022
Q1 		$1.6M Sell
9,875
-125
-1% -$18.2K 1.24% 23
2021
Q4 		$1.35M Buy
10,000
+51
+0.5% +$6.02K 1% 29
2021
Q3 		$1.07M Buy
9,949
+217
+2% +$24.8K 0.87% 35
2021
Q2 		$1.11M Buy
9,732
+1,081
+12% +$122K 0.91% 36
2021
Q1 		$936K Buy
8,651
+300
+4% +$32.1K 0.83% 40
2020
Q4 		$895K Buy
8,351
+3,001
+56% +$288K 0.83% 40
2020
Q3 		$469K Buy
5,350
+235
+5% +$22.1K 0.49% 49
2020
Q2 		$502K Sell
5,115
-6,410
-56% -$564K 0.59% 49
2020
Q1 		$878K Buy
11,525
+3,725
+48% +$317K 0.86% 38
2019
Q4 		$691K Buy
+7,800
New +$648K 0.52% 64
2014
Q1 		– Sell
-3,850
Closed -$203K – 115
2013
Q4 		$203K Buy
+3,850
New +$189K 0.19% 113

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aldebaran Financial's ABBV Position: Q1 2026 in Review

Aldebaran Financial increased its AbbVie (ABBV) stake by 6.9% in Q1 2026, buying an estimated $65.4K and bringing the position to 4,570 shares worth $994K. The position accounts for 0.94% of the portfolio, ranked #25.

Aldebaran Financial first reported a position in ABBV in Q4 2013 and has held it in 22 quarters since. The position peaked at $1.6M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Aldebaran Financial held 4,570 shares of AbbVie worth $994K as of Q1 2026.
  • Aldebaran Financial bought 295 AbbVie shares in Q1 2026, an estimated $65.4K.
  • AbbVie made up 0.94% of Aldebaran Financial's portfolio in Q1 2026, its #25 holding.
  • Aldebaran Financial first reported a position in AbbVie in Q4 2013 and has held it in 22 quarters since.
  • Aldebaran Financial's AbbVie position peaked at $1.6M in Q1 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aldebaran Financial's 13F filing for Q1 2026, filed 14 May 2026.